A possible role for ketorolac in the management of increased biliary drain output

Clin Res Hepatol Gastroenterol. 2023 May;47(6):102128. doi: 10.1016/j.clinre.2023.102128. Epub 2023 Apr 23.

Abstract

Percutaneous transhepatic biliary drainage is used to achieve biliary decompression in jaundiced patients with biliary obstruction. High drain output >2000 mL/day is rare, and can cause dehydration and electrolyte derangements, without effective treatments. We present the first patient, to our knowledge, who reacted to the use of the analgesic ketorolac with progressive reduction in biliary output, in the setting of malignant biliary obstruction from duodenal adenocarcinoma.

Keywords: Biliary obstruction; Ketorolac; NSAID; PTC.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / complications
  • Cholestasis* / etiology
  • Drainage
  • Humans
  • Jaundice*
  • Ketorolac / therapeutic use
  • Treatment Outcome

Substances

  • Ketorolac